Recent human trials of a new one-year-long immune-based treatment for post-polio syndrome, which can strike polio survivors ...

Concerns were raised in late 2024 when 94 confirmed polio-affected children were reported across 15 Nigerian states. No ...

Driving the news: The concerns have amped up in recent days following a report that an ally of Health and Human ... the body to produce its own antibodies against the virus that causes polio ...

A more affordable, lower-risk polio vaccine is on the horizon, research led by the University of Leeds has found.

The poliovirus can survive up to two months outside the body. Most of those infected never ... Nevertheless, poliomyelitis may soon become the second human disease, after smallpox, to be ...

Topline data were announced from a phase 2/3 trial evaluating Flebogamma 5% DIF (immune globulin intravenous ) in patients with post-polio syndrome (PPS).

Using formaldehyde, he killed the polio virus but kept it intact enough to trigger the body's response ... In 1957 he was ready for human trials of an vaccine people could swallow, not get ...